Overview
Rabie Chelbi practices practicing medicine in Paris, France.
Their clinical expertise encompasses Chronic Myelomonocytic Leukemia (CMML) and Sezary Syndrome.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rabie Chelbi
Is Rabie Chelbi a top-rated expert for Chronic Myelomonocytic Leukemia (CMML)?
MediFind is an objective health platform that identifies experts based on real-world data. Rabie Chelbi is classified as an Experienced expert for Chronic Myelomonocytic Leukemia (CMML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rabie Chelbi participate in research or clinical trials?
Yes. Rabie Chelbi has published 16 articles and abstracts on conditions like Chronic Myelomonocytic Leukemia (CMML). You can view a list of Rabie Chelbi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Myelomonocytic Leukemia (CMML)
- Sezary SyndromeChelbi isExperienced. Learn about Sezary Syndrome.